Technologies such as LC-MS/MS analysis and Meso Scale Discovery (MSD) are accelerating clinical and drug development initiatives. MSD technologies offer a robust platform for developing immunoassays for a spectrum of clinical and preclinical research. MSD offers ultra-low detection capacities and a broader dynamic range and handles complex study matrices. However, similar to LC-MS/MS method […]